Toll Free: 1-888-928-9744
Published: Aug, 2017 | Pages:
104 | Publisher: QYResearch
Industry: ICT | Report Format: Electronic (PDF)
This report studies the global Parkinsons Disease Drugs market, analyzes and researches the Parkinsons Disease Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like GSK Novartis Boehringer Ingelheim Teva Pharmaceutical Abbvie Merck Akorn Kyowa Hakko Kirin Pharma Astellas Pharma Desitin Arzneimittel Endo Pharmaceuticals F.Hoffmann-La Roche H.Lundbeck Valeant Apokyn Orion Stada Arzneimittel US WorldMeds Valeant Pharmaceuticals Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Parkinsons Disease Drugs can be split into Madopar Sinemet-CR Trastal COMT Inhibitor Other Market segment by Application, Parkinsons Disease Drugs can be split into Under 40 Years Old 40-65 Years Old Above 65 Years Old If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents Global Parkinsons Disease Drugs Market Size, Status and Forecast 2022 1 Industry Overview of Parkinsons Disease Drugs 1.1 Parkinsons Disease Drugs Market Overview 1.1.1 Parkinsons Disease Drugs Product Scope 1.1.2 Market Status and Outlook 1.2 Global Parkinsons Disease Drugs Market Size and Analysis by Regions 1.2.1 United States 1.2.2 EU 1.2.3 Japan 1.2.4 China 1.2.5 India 1.2.6 Southeast Asia 1.3 Parkinsons Disease Drugs Market by Type 1.3.1 Madopar 1.3.2 Sinemet-CR 1.3.3 Trastal 1.3.4 COMT Inhibitor 1.3.5 Other 1.4 Parkinsons Disease Drugs Market by End Users/Application 1.4.1 Under 40 Years Old 1.4.2 40-65 Years Old 1.4.3 Above 65 Years Old 2 Global Parkinsons Disease Drugs Competition Analysis by Players 2.1 Parkinsons Disease Drugs Market Size (Value) by Players (2016 and 2017) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future 3 Company (Top Players) Profiles 3.1 GSK 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017) 3.1.5 Recent Developments 3.2 Novartis 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017) 3.2.5 Recent Developments 3.3 Boehringer Ingelheim 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017) 3.3.5 Recent Developments 3.4 Teva Pharmaceutical 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017) 3.4.5 Recent Developments 3.5 Abbvie 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017) 3.5.5 Recent Developments 3.6 Merck 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017) 3.6.5 Recent Developments 3.7 Akorn 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017) 3.7.5 Recent Developments 3.8 Kyowa Hakko Kirin Pharma 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017) 3.8.5 Recent Developments 3.9 Astellas Pharma 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017) 3.9.5 Recent Developments 3.10 Desitin Arzneimittel 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017) 3.10.5 Recent Developments 3.11 Endo Pharmaceuticals 3.12 F.Hoffmann-La Roche 3.13 H.Lundbeck 3.14 Valeant 3.15 Apokyn 3.16 Orion 3.17 Stada Arzneimittel 3.18 US WorldMeds 3.19 Valeant Pharmaceuticals 4 Global Parkinsons Disease Drugs Market Size by Type and Application (2012-2017) 4.1 Global Parkinsons Disease Drugs Market Size by Type (2012-2017) 4.2 Global Parkinsons Disease Drugs Market Size by Application (2012-2017) 4.3 Potential Application of Parkinsons Disease Drugs in Future 4.4 Top Consumer/End Users of Parkinsons Disease Drugs 5 United States Parkinsons Disease Drugs Development Status and Outlook 5.1 United States Parkinsons Disease Drugs Market Size (2012-2017) 5.2 United States Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017) 6 EU Parkinsons Disease Drugs Development Status and Outlook 6.1 EU Parkinsons Disease Drugs Market Size (2012-2017) 6.2 EU Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017) 7 Japan Parkinsons Disease Drugs Development Status and Outlook 7.1 Japan Parkinsons Disease Drugs Market Size (2012-2017) 7.2 Japan Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017) 8 China Parkinsons Disease Drugs Development Status and Outlook 8.1 China Parkinsons Disease Drugs Market Size (2012-2017) 8.2 China Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017) 9 India Parkinsons Disease Drugs Development Status and Outlook 9.1 India Parkinsons Disease Drugs Market Size (2012-2017) 9.2 India Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017) 10 Southeast Asia Parkinsons Disease Drugs Development Status and Outlook 10.1 Southeast Asia Parkinsons Disease Drugs Market Size (2012-2017) 10.2 Southeast Asia Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017) 11 Market Forecast by Regions, Type and Application (2017-2022) 11.1 Global Parkinsons Disease Drugs Market Size (Value) by Regions (2017-2022) 11.1.1 United States Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022) 11.1.2 EU Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022) 11.1.3 Japan Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022) 11.1.4 China Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022) 11.1.5 India Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022) 11.1.6 Southeast Asia Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022) 11.2 Global Parkinsons Disease Drugs Market Size (Value) by Type (2017-2022) 11.3 Global Parkinsons Disease Drugs Market Size by Application (2017-2022) 12 Parkinsons Disease Drugs Market Dynamics 12.1 Parkinsons Disease Drugs Market Opportunities 12.2 Parkinsons Disease Drugs Challenge and Risk 12.2.1 Competition from Opponents 12.2.2 Downside Risks of Economy 12.3 Parkinsons Disease Drugs Market Constraints and Threat 12.3.1 Threat from Substitute 12.3.2 Government Policy 12.3.3 Technology Risks 12.4 Parkinsons Disease Drugs Market Driving Force 12.4.1 Growing Demand from Emerging Markets 12.4.2 Potential Application 13 Market Effect Factors Analysis 13.1 Technology Progress/Risk 13.1.1 Substitutes 13.1.2 Technology Progress in Related Industry 13.2 Consumer Needs Trend/Customer Preference 13.3 External Environmental Change 13.3.1 Economic Fluctuations 13.3.2 Other Risk Factors 14 Research Finding/Conclusion 15 Appendix Methodology Analyst Introduction Data Source
List of Tables and FiguresList of Tables and Figures Figure Parkinsons Disease Drugs Product Scope Figure Global Parkinsons Disease Drugs Market Size (Million USD) (2012-2017) Table Global Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure Global Parkinsons Disease Drugs Market Share by Regions in 2016 Figure United States Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure EU Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure Japan Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure China Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure India Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure Southeast Asia Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure Global Parkinsons Disease Drugs Market Share by Type in 2016 Figure Madopar Market Size (Million USD) and Growth Rate (2012-2017) Figure Sinemet-CR Market Size (Million USD) and Growth Rate (2012-2017) Figure Trastal Market Size (Million USD) and Growth Rate (2012-2017) Figure COMT Inhibitor Market Size (Million USD) and Growth Rate (2012-2017) Figure Other Market Size (Million USD) and Growth Rate (2012-2017) Figure Global Parkinsons Disease Drugs Market Share by Application in 2016 Table Key Downstream Customer in Under 40 Years Old Figure Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate in Under 40 Years Old (2012-2017) Table Key Downstream Customer in 40-65 Years Old Figure Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate in 40-65 Years Old (2012-2017) Table Key Downstream Customer in Above 65 Years Old Figure Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate in Above 65 Years Old (2012-2017) Table Parkinsons Disease Drugs Market Size (Million USD) by Players (2016 and 2017) Figure Parkinsons Disease Drugs Market Size Share by Players in 2016 Figure Parkinsons Disease Drugs Market Size Share by Players in 2017 Table GSK Basic Information List Table Parkinsons Disease Drugs Business Revenue (Million USD) of GSK (2012-2017) Figure GSK Parkinsons Disease Drugs Business Revenue Market Share in 2016 Table Novartis Basic Information List Table Parkinsons Disease Drugs Business Revenue (Million USD) of Novartis (2012-2017) Figure Novartis Parkinsons Disease Drugs Business Revenue Market Share in 2016 Table Boehringer Ingelheim Basic Information List Table Parkinsons Disease Drugs Business Revenue (Million USD) of Boehringer Ingelheim (2012-2017) Figure Boehringer Ingelheim Parkinsons Disease Drugs Business Revenue Market Share in 2016 Table Teva Pharmaceutical Basic Information List Table Parkinsons Disease Drugs Business Revenue (Million USD) of Teva Pharmaceutical (2012-2017) Figure Teva Pharmaceutical Parkinsons Disease Drugs Business Revenue Market Share in 2016 Table Abbvie Basic Information List Table Parkinsons Disease Drugs Business Revenue (Million USD) of Abbvie (2012-2017) Figure Abbvie Parkinsons Disease Drugs Business Revenue Market Share in 2016 Table Merck Basic Information List Table Parkinsons Disease Drugs Business Revenue (Million USD) of Merck (2012-2017) Figure Merck Parkinsons Disease Drugs Business Revenue Market Share in 2016 Table Akorn Basic Information List Table Parkinsons Disease Drugs Business Revenue (Million USD) of Akorn (2012-2017) Figure Akorn Parkinsons Disease Drugs Business Revenue Market Share in 2016 Table Kyowa Hakko Kirin Pharma Basic Information List Table Parkinsons Disease Drugs Business Revenue (Million USD) of Kyowa Hakko Kirin Pharma (2012-2017) Figure Kyowa Hakko Kirin Pharma Parkinsons Disease Drugs Business Revenue Market Share in 2016 Table Astellas Pharma Basic Information List Table Parkinsons Disease Drugs Business Revenue (Million USD) of Astellas Pharma (2012-2017) Figure Astellas Pharma Parkinsons Disease Drugs Business Revenue Market Share in 2016 Table Desitin Arzneimittel Basic Information List Table Parkinsons Disease Drugs Business Revenue (Million USD) of Desitin Arzneimittel (2012-2017) Figure Desitin Arzneimittel Parkinsons Disease Drugs Business Revenue Market Share in 2016 Table Endo Pharmaceuticals Basic Information List Table Parkinsons Disease Drugs Business Revenue (Million USD) of Endo Pharmaceuticals (2012-2017) Figure Endo Pharmaceuticals Parkinsons Disease Drugs Business Revenue Market Share in 2016 Table F.Hoffmann-La Roche Basic Information List Table Parkinsons Disease Drugs Business Revenue (Million USD) of F.Hoffmann-La Roche (2012-2017) Figure F.Hoffmann-La Roche Parkinsons Disease Drugs Business Revenue Market Share in 2016 Table H.Lundbeck Basic Information List Table Parkinsons Disease Drugs Business Revenue (Million USD) of H.Lundbeck (2012-2017) Figure H.Lundbeck Parkinsons Disease Drugs Business Revenue Market Share in 2016 Table Valeant Basic Information List Table Parkinsons Disease Drugs Business Revenue (Million USD) of Valeant (2012-2017) Figure Valeant Parkinsons Disease Drugs Business Revenue Market Share in 2016 Table Apokyn Basic Information List Table Parkinsons Disease Drugs Business Revenue (Million USD) of Apokyn (2012-2017) Figure Apokyn Parkinsons Disease Drugs Business Revenue Market Share in 2016 Table Orion Basic Information List Table Parkinsons Disease Drugs Business Revenue (Million USD) of Orion (2012-2017) Figure Orion Parkinsons Disease Drugs Business Revenue Market Share in 2016 Table Stada Arzneimittel Basic Information List Table Parkinsons Disease Drugs Business Revenue (Million USD) of Stada Arzneimittel (2012-2017) Figure Stada Arzneimittel Parkinsons Disease Drugs Business Revenue Market Share in 2016 Table US WorldMeds Basic Information List Table Parkinsons Disease Drugs Business Revenue (Million USD) of US WorldMeds (2012-2017) Figure US WorldMeds Parkinsons Disease Drugs Business Revenue Market Share in 2016 Table Valeant Pharmaceuticals Basic Information List Table Parkinsons Disease Drugs Business Revenue (Million USD) of Valeant Pharmaceuticals (2012-2017) Figure Valeant Pharmaceuticals Parkinsons Disease Drugs Business Revenue Market Share in 2016 Table Global Parkinsons Disease Drugs Market Size (Million USD) by Type (2012-2017) Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2012 Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2013 Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2014 Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2015 Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2016 Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2017 Table Global Parkinsons Disease Drugs Market Size (Million USD) by Application (2012-2017) Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2012 Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2013 Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2014 Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2015 Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2016 Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2017 Table Top Consumer/End Users of Parkinsons Disease Drugs Figure United States Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table United States Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017) Figure United States Parkinsons Disease Drugs Market Size Share by Players in 2016 Figure United States Parkinsons Disease Drugs Market Size Share by Players in 2017 Figure EU Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table EU Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017) Figure EU Parkinsons Disease Drugs Market Size Share by Players in 2016 Figure EU Parkinsons Disease Drugs Market Size Share by Players in 2017 Figure Japan Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table Japan Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017) Figure Japan Parkinsons Disease Drugs Market Size Share by Players in 2016 Figure Japan Parkinsons Disease Drugs Market Size Share by Players in 2017 Figure China Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table China Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017) Figure China Parkinsons Disease Drugs Market Size Share by Players in 2016 Figure China Parkinsons Disease Drugs Market Size Share by Players in 2017 Figure India Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table India Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017) Figure India Parkinsons Disease Drugs Market Size Share by Players in 2016 Figure India Parkinsons Disease Drugs Market Size Share by Players in 2017 Figure Southeast Asia Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table Southeast Asia Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017) Figure Southeast Asia Parkinsons Disease Drugs Market Size Share by Players in 2016 Figure Southeast Asia Parkinsons Disease Drugs Market Size Share by Players in 2017 Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Regions (2017-2022) Table Global Parkinsons Disease Drugs Market Size (Million USD) by Regions (2017-2022) Figure Global Parkinsons Disease Drugs Market Size Share by Regions in 2017 Figure Global Parkinsons Disease Drugs Market Size Share by Regions in 2022 Figure United States Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022) Figure EU Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022) Figure Japan Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022) Figure China Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022) Figure India Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022) Figure Southeast Asia Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022) Table Global Parkinsons Disease Drugs Market Size (Million USD) by Type (2017-2022) Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2017 Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2022 Table Global Parkinsons Disease Drugs Market Size (Million USD) by Application (2017-2022) Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2017 Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2022
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.